Morning Headlines 8/9/13

Allscripts announces second quarter 2013 results

Allscripts announces Q2 results: revenue of $344.8 million and $0.05 EPS, compared to $370 million and $0.16 EPS for the same period in 2012. Paul Black is optimistic, based on strong bookings for the quarter driven primarily from its population health solutions.

Nuance Gains as Icahn Builds Stake in Software Maker

Investment billionaire and hostile takeover specialist Carl Icahn has increased his percent ownership of Nuance from nine percent to 16 percent, according to an SEC filing.

CDS Surveillance Significantly Impacts Patient Outcomes

A KLAS survey of 140 providers evaluates clinical surveillance systems which as a whole seem to be delivering on promises of improved outcomes, as 79 percent of customers report that utilizing the technology has a moderate to significant impact on clinical outcomes.

Inova Translational Medicine Institute and GNS Healthcare Partner To Advance Diagnosis and Prevention of Preterm Birth

The Inova Translational Medicine Institute and GNS Healthcare will partner on a commercial project aimed at developing software that will use sophisticated algorithms and datasets to create personalized prediction of preterm birth risk and more accurate gestational length estimates.